Studies have shown that RUVBL1/2 interferes with the RNA binding activity of YTHDF1, reducing the translation of cancer-related genes and inhibiting tumor cell proliferation and invasion, demonstrating significant antitumor effects in CRC (179). Here, YTHDF1 is linked to neoplasm.